ANIP vs SGEN
ANI Pharmaceuticals Inc (ANIP) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
SGEN (SGEN) common stock.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
SGEN does not have a complete income-statement cache yet.
ANIP currently screens at market cap $1.41B.
Not investment advice. Open the ANIP and SGEN stock pages for the full models.
Not investment advice.